May 22/2026

Thousand Oaks Biologics Honored with 2026 Forbes China Industry Development Leading Enterprise Award

Shanghai, China--(Newsfile Corp. - May 22, 2026) - On March 18, 2026, Frost & Sullivan and Forbes China Group jointly hosted the 2026 FORBES CHINA PIONEER INNOVATORS IN INDUSTRY DEVELOPMENT SELECTION GALA BANQUET at the Bulgari Hotel in Shanghai. The

May 20/2026

Thousand Oaks Biologics Scaling Biologics through Integrated Manufacturing Systems

The science of biologics has never moved faster. Therapeutic modalities are multiplying, targeting is growing more precise and molecular architectures are becoming more complex. The discovery engine is running at full speed, but the path to manufactu

Oct 29/2025

Thousand Oaks Biologics Showcases Integrated ADC CRDMO Solutions & Media Innovation for Industrialization at CPHI Frankfurt 2025

FRANKFURT, Germany, Oct. 29, 2025 /PRNewswire/ -- Thousand Oaks Biologics, a leading Asia-based CRDMO specializing in macromolecules, today announced its participation in CPHI Frankfurt 2025, held from October 28-30.

Oct 28/2025

Shanghai’s JSBio Expands Into Cultivated Meat to Tap China’s Future Food Opportunity

Oct 13/2025

Thousand Oaks Biologics Shanghai ADC Site receives EU QP Declaration

SHANGHAI, Oct. 13, 2025 /PRNewswire/ -- Thousand Oaks Biologics' antibody-drug conjugate (ADC) manufacturing site successfully passed an audit conducted by a European Union Qualified Person (QP) and formally received a QP Declaration. This milestone

May 22/2023

Thousand Oaks Biologics and GeneQuantum Healthcare Signed A Strategic Partnership Agreement for ADC Drug Development